We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

98 hedge funds and large institutions have $1.18B invested in IVERIC bio, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 13

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

54% more capital invested

Capital invested by funds: $768M → $1.18B (+$412M)

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

34% more funds holding

Funds holding: 7398 (+25)

58% less call options, than puts

Call options by funds: $2.34M | Put options by funds: $5.54M

Holders
98
Holders Change
+25
Holders Change %
+34.25%
% of All Funds
2.82%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
39
Increased
38
Reduced
15
Closed
13
Calls
$2.34M
Puts
$5.54M
Net Calls
-$3.2M
Net Calls Change
+$3.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$3.27M +$538K +14,655 +23%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$3.05M +$2.64M +72,062 New
MAA
28
Managed Account Advisors
New Jersey
$2.99M -$103K -2,797 -4%
TCIM
29
TIAA CREF Investment Management
New York
$2.25M +$652K +17,758 +50%
TG
30
TCW Group
California
$2.09M +$27.2K +742 +2%
CCM
31
Cupps Capital Management
Illinois
$2.04M +$1.77M +48,355 New
Millennium Management
32
Millennium Management
New York
$1.88M +$1.63M +44,358 New
BIM
33
BlackRock Investment Management
Delaware
$1.6M +$405K +11,046 +41%
BBA
34
Baker Bros. Advisors
New York
$1.56M
AllianceBernstein
35
AllianceBernstein
Tennessee
$1.41M +$1.21M +33,000 +11,000%
Caisse de Depot et Placement du Quebec (CDPQ)
36
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$1.39M +$1.2M +32,818 New
ROTUOC
37
Regents of the University of California
California
$1.36M +$1.18M +32,220 New
EI
38
EAM Investors
California
$1.35M +$1.17M +31,932 New
PP
39
Paloma Partners
Connecticut
$1.27M +$1.1M +30,000 New
Charles Schwab
40
Charles Schwab
California
$1.23M +$269K +7,324 +34%
GC
41
Guggenheim Capital
Illinois
$1.23M +$1.07M +29,028 New
CS
42
Credit Suisse
Switzerland
$1.21M +$820K +22,339 +363%
Ameriprise
43
Ameriprise
Minnesota
$1.17M +$1.02M +27,710 New
Wells Fargo
44
Wells Fargo
California
$1.14M +$26.1K +712 +3%
LCG
45
Lisanti Capital Growth
New York
$1.14M +$985K +26,835 New
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.07M +$301K +8,200 +48%
ZDA
47
Zweig-DiMenna Associates
New York
$1.06M
AL
48
Airain Ltd
Guernsey
$959K +$832K +22,668 New
RFC
49
Russell Frank Company
Washington
$858K +$783K +21,326 New
Federated Hermes
50
Federated Hermes
Pennsylvania
$846K +$183K +5,000 +33%

ISEE Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2014, worth a combined $1.18B — up 54% from $768M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ISEE positions and 13 closed out — a net gain of 26 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $68.3M. The largest seller was Clarus Ventures, cutting an estimated $55M.

  • 98 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2014, up from 73 in Q1 2014.
  • Funds reported $1.18B of IVERIC bio, Inc. Common Stock stock for Q2 2014, up 54% quarter-over-quarter.
  • 39 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2014 and 13 closed out, a net change of +26 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2014 was Fidelity Investments, an estimated $68.3M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2014 was Clarus Ventures, an estimated $55M sold.

Based on aggregated 13F filings for Q2 2014.